Pathology Services in Australia - Market Research Report (2014-2029)
Melbourne, Australia
Last Updated: May 2024
ANZSIC Q8521Revenue
$4.9bn
Past 5-Year Growth
Profit
$XXX.Xm
Employees
28,189
Businesses
480
Wages
$X.Xbn
Pathology Services in Australia industry analysis
Pathology services providers supply vital information to help doctors diagnose and manage various diseases. Continual technological developments are increasing the range of available tests, boosting the range of pathology referrals. Australia's ageing population and the increased prevalence of chronic illnesses are also driving strong underlying demand for health services and associated referrals for pathology services. Medicare funding is supporting this demand, with the number of Medicare-funded services steadily rising, although the lack of MBS indexation is eroding industry profit margins.
Trends and Insights
- Private pathology providers played a central role in providing COVID-19 testing services. This created a new revenue stream, with private pathology providers benefiting from record Medicare-funded service volumes. Volume growth is currently sluggish as Australians defer GP visits.
- The Pathology Services industry provides a range of specialised services. Industry services are divided according to the type of medical inquiry they respond to, the type of staff that conduct them, and the equipment and facilities they require.
- The supply of pathology services by state and territory largely reflects the residency and age distributions of the population throughout Australia. Eastern seaboard states account for just under 80% of all Medicare pathology services in Australia.
- Despite the dominant position of the three largest pathology providers, the Pathology Services industry is still a highly competitive industry. Smaller pathology providers often compete in minor geographic or niche markets.
Industry Overview
Market size and recent performance (2014-2029)
Industry revenue has grown at a CAGR of 0.3 % over the past five years, to reach an estimated $4.9bn in 2024.
Trends and Insights
The COVID-19 pandemic created a new revenue stream, although this has since dried up
- The pandemic created a spike in demand for pathology services, with private pathology providers playing a central role in providing COVID-19 testing services to detect and control outbreaks.
- Additional trends and insights available with purchase
Source: IBISWorld
Industry outlook (2024-2029)
Market size is projected to grow over the next five years.
Trends and Insights
Short-term challenges as the industry retreats from a COVID-induced high
- The industry is currently contending with changing dynamics as it continues to revert to its pre-COVID-19 operating environment. Short-term challenges include lower volumes stemming from a relative drop in the number of Australians visiting their GP and the associated reduction in referrals.
Biggest companies in the Pathology Services in Australia
| Company | Market Share (%)
2024 | Revenue ($m)
2024 |
|---|---|---|
Sonic Healthcare | 1,910.0 | |
Healius | 1,240.0 | |
Australian Clinical Labs | 660.0 |
To view the market share and analysis for all 3 top companies in this industry, view purchase options.
Products & Services Segmentation
Source: IBISWorld
Industry revenue is measured across several distinct product and services lines, including Other clinical pathology, Chemical pathology and Anatomical pathology. Other clinical pathology is the largest segment of the Pathology Services in Australia.
Trends and Insights
Automation benefits chemical pathology providers
- Chemical pathology uses biochemical tests to evaluate and diagnose patients. Procedures include general biochemistry tests, metabolic tests and toxicology tests. It is the largest subcategory within Pathology Services.
- More insights available in the full report
Widen you competitive advantage with related industries
Competitors
- There are no industries to display.
Complementors
- Pharmaceutical Product Manufacturing in Australia
- Environmental Science Services in Australia
- Specialist Medical Services in Australia
- Diagnostic Imaging Services in Australia
International industries
- Diagnostic & Medical Laboratories in the US
- Cryogenic Biobanking Services in the US
- Toxicology Laboratories in the US
- Diagnostic Imaging Centers in the US
- Pathology and Diagnostic Imaging Services in New Zealand
Table of Contents
About this industry
Industry definition
Pathology providers operate pathology laboratories and collection centres. Pathology services that are provided by public laboratories operating within general hospitals are not included in the industry.
What's included in this industry?
Chemical pathologyAnatomical pathologyOther clinical pathology including immunology/immunopathology, genetics/cytogenetics and prenatal testingMicrobiology HaematologyCompanies
Sonic HealthcareHealiusAustralian Clinical LabsPurchase this report to view all 3 major companies in this industry.
Related Terms
HAEMATOLOGYMICROBIOLOGYCYTOPATHOLOGYCYTOGENETICSIMMUNOLOGYAPPROVED COLLECTION CENTREIndustry Code
ANZSIC 8520 - Pathology Services in Australia
Performance
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Analyst insights
Private pathology providers played a central role in providing COVID-19 testing services. This created a new revenue stream, with private pathology providers benefiting from ...
In this chapter (4)
- Current Performance
- Outlook
- Volatility
- Life Cycle
Key metrics
- Annual Revenue, Recent Growth, Forecast, Revenue Volatility
- Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
- Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
- Total Profit, Profit Margin, Profit per Business
Charts
- Revenue, including historical (2014-2023) and forecast (2024-2029)
- Employees, including historical (2014-2023) and forecast (2024-2029)
- Businesses, including historical (2014-2023) and forecast (2024-2029)
- Profit, including historical (2014-2024)
- Industry Volatility vs. Revenue Growth
- Industry Life Cycle
Detailed analysis
- Trends in supply, demand and current events that are driving current industry performance
- Expected trends, economic factors and ongoing events that drive the industry's outlook
- Key success factors for businesses to overcome volatility
- How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.
Products and Markets
Learn about an industry's products and services, markets and trends in international trade.
Analyst insight
The Pathology Services industry provides a range of specialised services. Industry services are divided according to the type of medical inquiry they respond to, the type of ...
In this chapter
- Products & Services
- Major Markets
Key metrics
- Largest market segment and value in 2024
- Product innovation level
Charts
- Products & services segmentation in 2024
- Major market segmentation in 2024
Detailed analysis
- Trends impacting the recent performance of the industry's various segments
- Innovations in the industry's product or service offering, specialization or delivery method
- Key factors that successful businesses consider in their offerings
- Buying segments and key trends influencing demand for industry products and services
Geographic Breakdown
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Analyst insights
The supply of pathology services by state and territory largely reflects the residency and age distributions of the population throughout Australia. Eastern seaboard states a...
In this chapter (1)
- Business Locations
Charts
- Share of revenue, establishment, wages and employment in each region
- Share of population compared to establishments in each region in 2024
Tables
- Number and share of establishments in each region in 2024
- Number and share of revenue each region accounts for in 2024
- Number and share of wages each region accounts for in 2024
- Number and share of employees in each region in 2024
Detailed analysis
- Geographic spread of the industry across Asia Pacific, and trends associated with changes in the business landscape
- Key success factors for businesses to use location to their advantage
Competitive Forces
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Analyst insights
Despite the dominant position of the three largest pathology providers, the Pathology Services industry is still a highly competitive industry. Smaller pathology providers of...
In this chapter (4)
- Concentration
- Barriers to Entry
- Substitutes
- Buyer & Supplier Analysis
Key metrics
- Industry concentration level
- Industry competition level and trend
- Barriers to entry level and trend
- Substitutes level and trend
- Buyer power level and trend
- Supplier power level and trend
Charts
- Market share concentration among the top 4 suppliers from 2019-2024
- Supply chain including upstream supplying industries and downstream buying industries, flow chart
Detailed analysis
- Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
- Key success factors for businesses to manage the competitive environment of the industry.
- Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
- Key success factors for potential entrants to overcome barriers to entry.
- Competitive threats from potential substitutes for the industry’s own products and services.
- Key success factors for how successful businesses can compete with substitutes.
- Advantages that buyers have to keep favorable purchasing conditions.
- Advantages that suppliers have to maintain favorable selling conditions.
- Key success factors for how businesses can navigate buyer and supplier power.
Companies
Learn about the performance of the top companies in the industry.
Analyst insights
The largest three players dominate the industry, accounting for over three-quarters of industry revenue and over 80% of approved collection centres. The majority of Medicare ...
In this chapter
- Market Share Concentration
- Companies
- Company Spotlights
Charts
- Industry market share by company in 2020 through 2024
- Major companies in the industry, including market share, revenue, profit and profit margin in 2024
- Overview of Sonic Healthcare's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Healius's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Australian Clinical Labs's performance by revenue, market share and profit margin from 2018 through 2024
Detailed analysis
- Description and key data for Sonic Healthcare, and factors influencing its performance in the industry
- Description and key data for Healius, and factors influencing its performance in the industry
- Description and key data for Australian Clinical Labs, and factors influencing its performance in the industry
External Environment
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Analyst insights
Under Australia's national health insurance scheme, Medicare benefits are payable for privately provided pathology services. Benefits are based on the Medicare Benefits Schem...
In this chapter
- External Drivers
- Regulation & Policy
- Assistance
Key metrics
- Regulation & policy level and trend
- Assistance level and trend
Charts
- Regulation & Policy historical data and forecast (2014-2029)
- Assistance historical data and forecast (2014-2029)
Detailed analysis
- Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
- Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
- Key governmental and non-governmental groups or policies that may provide some relief for industry operators.
Financial Benchmarks
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Analyst insights
Recent consolidation has partially supported profit margins, with the larger pathology providers benefiting from economies of scale. The construction of large central laborat...
In this chapter
- Cost Structure
- Financial Ratios
- Key Ratios
Key metrics
- Profit margin, and how it compares to the sector-wide margin
- Average wages, and how it compares to the sector-wide average wage
- Largest cost component as a percentage of revenue
- Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio
Charts
- Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Investment vs. share of economy
Data tables
- Cash Flow & Debt Service Ratios (2014-2029)
- Revenue per Employee (2014-2029)
- Revenue per Enterprise (2014-2029)
- Employees per Establishment (2014-2029)
- Employees per Enterprise (2014-2029)
- Average Wage (2014-2029)
- Wages/Revenue (2014-2029)
- Establishments per Enterprise (2014-2029)
- IVA/Revenue (2014-2029)
- Imports/Demand (2014-2029)
- Exports/Revenue (2014-2029)
Detailed analysis
- Trends in the cost component for industry operators and their impact on industry costs and profitability
Key Statistics
Industry Data
Data Tables
Including values and annual change:
- Revenue (2014-2029)
- IVA (2014-2029)
- Establishments (2014-2029)
- Enterprises (2014-2029)
- Employment (2014-2029)
- Exports (2014-2029)
- Imports (2014-2029)
- Wages (2014-2029)
Methodology
How are IBISWorld reports created?
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
What data sources do IBISWorld analysts use?
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in Australia include:
- Australian Bureau of Statistics
- Australian Taxation Office
- Australian Securities & Investments Commission
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
- Industry and trade associations
- Industry federations or regulators
- Major industry players annual or quarterly filings
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
How does IBISWorld forecast its data?
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Frequently Asked Questions
Unlock comprehensive answers and precise data upon purchase. View purchase options.
What is the market size of the Pathology Services industry in Australia in 2024?
The market size of the Pathology Services industry in Australia is $4.9bn in 2024.
How many businesses are there in the Pathology Services in Australia industry in 2024?
There are 480 businesses in the Pathology Services industry in Australia, which has grown at a CAGR of 6.4 % between 2019 and 2024.
Has the Pathology Services industry in Australia grown or declined over the past 5 years?
The market size of the Pathology Services industry in Australia has been growing at a CAGR of 0.3 % between 2019 and 2024.
What is the forecast growth of the Pathology Services industry in Australia over the next 5 years?
Over the next five years, the Pathology Services industry in Australia is expected to grow.
What are the biggest companies in the Pathology Services market in Australia?
The biggest companies operating in the Pathology Services market in Australia are Sonic Healthcare, Healius and Australian Clinical Labs
What does the Pathology Services in Australia include?
Chemical pathology and Anatomical pathology are part of the Pathology Services industry.
Which companies have the highest market share in the Pathology Services in Australia?
The company holding the most market share in Australia is Sonic Healthcare.
How competitive is the Pathology Services industry in Australia?
The level of competition is high and increasing in the Pathology Services industry in Australia.
